Nutrient quality
Calcium ascorbate is favorable, but most extracts lack species, active markers, or potency details. Cordyceps is moderate, while bromelain, nettle, quercetin, and several botanicals are underdosed.
.| $ 27.02 |
Cordyceps, bromelain, quercetin, citrus bioflavonoids, pine bark, nettle, and feverfew create a recognizable respiratory and inflammatory-support theme. Calcium ascorbate adds a modest amount of buffered vitamin C.
Most actives are present at small amounts, and bromelain lacks enzyme activity units. Cordyceps has no species, source-material, extraction, or marker information, while the vitamin K2 subtype is not identified.
The formula is poorly aligned with testosterone support and only moderately useful for broad inflammatory balance. Butterbur is not stated to be free of pyrrolizidine alkaloids, which is a major product-specific safety uncertainty.
Calcium ascorbate is favorable, but most extracts lack species, active markers, or potency details. Cordyceps is moderate, while bromelain, nettle, quercetin, and several botanicals are underdosed.
.All ingredient weights are listed, but active-marker potency is widely missing. The supplied data does not include a complete inactive ingredient list.
.The aggregate satisfaction measure is strong enough to support a favorable first impression. Missing feedback themes leave repeat complaints and purpose fit uncertain despite adequate volume.
.The moderate price is hard to justify given weak doses and large quality gaps. Each serving is affordable, but the effective dose depth is limited.
.The broad botanical and enzyme blend touches several inflammatory, histamine, and antioxidant pathways.
Most goal-relevant actives are present at low amounts and lack potency standardization. Menaquinone may reduce warfarin's effect, while butterbur should be verified as free of pyrrolizidine alkaloids before use.
| Ingredient | Amount per serving |
|---|---|
Vitamin C (Calcium Ascorbate) | 125 mg |
Cordyceps extract | 250 mg |
Citrus Bioflavonoids Complex | 125 mg |
Quercetin | 50 mg |
Butterbur extract | 37.5 mg |
Bromelain (Pineapple) | 25 mg |
Feverfew leaf extract | 25 mg |
Stinging Nettle root extract | 25 mg |
Pine bark extract | 25 mg |
Menaquinone | 50 mcg |
The formula provides only 25 mg of stinging nettle root extract, leaving nettle as a minor part of the blend. Root is poorly aligned with the respiratory and allergy-focused ingredients, where leaf would be the more relevant plant part. The amount is clearly disclosed and the serving cost is moderate, but the low dose and absent standardization weaken its fit.
The cordyceps amount reaches the collection's moderate dose band, but the label omits species, source material, extraction method, and active-marker standardization. The low serving cost partly offsets these substantial quality and transparency gaps. Butterbur is not identified as PA-free, so residual pyrrolizidine alkaloids could pose a liver toxicity risk.
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.